Keyphrases
Additional Therapy
12%
Adjunctive Therapy
12%
Age of Infection
12%
Anti-tuberculosis Drugs
12%
Associated Proteins
12%
Blood Concentration
12%
Bone Disc
12%
Concentration Change
12%
Developing Countries
12%
Dose Effect
12%
Doxycycline
100%
Epithelial Cells
12%
Extracellular Matrix Protein 1 (ECM1)
12%
Granulation Tissue
12%
Group-based
12%
Healing Rate
12%
Histopathological Examination
12%
Human Systems
12%
Immunohistochemical Examination
12%
Incubation Period
12%
Inflammatory Cell Infiltration
12%
Intervertebral Disc
25%
Least Developed Countries
12%
Lymphocyte Cell
12%
Macrophage Cells
12%
Matrix metalloproteinase-1 (MMP-1)
100%
Multidrug-resistant Tuberculosis (MDR-TB)
12%
Mycobacterium Tuberculosis (M. tb)
12%
New Zealand White Rabbit
12%
Once-daily
12%
Pathological Findings
12%
Patient Risk
12%
Placebo
12%
Polymerase Chain Reaction
25%
Potential Matrix
100%
Rabbit Model
100%
Spinal Tuberculosis
100%
Spine
12%
Treatment Duration
12%
Treatment Research
12%
Tuberculosis
12%
Tuberculosis Treatment
25%
Vertebral Body
12%
Vertebral Endplate
12%
Virulence
12%
Pharmacology, Toxicology and Pharmaceutical Science
Diseases
12%
Doxycycline
100%
Drug Resistant Tuberculosis
12%
Granulation Tissue
12%
Incubation Time
12%
Infection
25%
Interstitial Collagenase
100%
Leporidae
50%
Mycobacterium Tuberculosis
12%
New Zealand White (Rabbit)
12%
Placebo
12%
Rabbit Model
100%
Tuberculostatic Agent
12%
Tuberculous Spondylitis
100%
Veterinary Science and Veterinary Medicine
Body of Vertebra
16%
Histopathological Examination
16%
Infectious Disease
33%
Intervertebral Disk
33%
Leporidae
100%
Lymphocyte
16%
Macrophage
16%
Mycobacterium tuberculosis
16%
Polymerase Chain Reaction
33%
Spondylitis
100%
Vertebral Column
16%